poisar

Stocks · News reference

Glucotrack's Lōkahi Therapeutic Subsidiary Initiates Good Manufacturing Practice Production Campaign For LT-100

Aug 25, 2026, 12:03 PMBenzinga Newsdesk

Lōkahi Therapeutics™ Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced that it has started its initial Good Manufacturing Practice (GMP) manufacturing campaign for LT-100 (pure honeybee venom), the

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

GCTK
Source
benzinga
Observed
Aug 25, 2026, 12:03 PM
Checked
Aug 25, 2026, 12:03 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading